Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper

Title

Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper

Authors

Keywords

metabolic effect, diabetes, targeted therapy, immunotherapy, hyperglycemia, dyslipidemia, hypercholesterolemia, hypertriglyceridemia

Journal

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Volume 154, Issue -, Pages 103066

Publisher

Elsevier BV

Online

2020-08-16

DOI

10.1016/j.critrevonc.2020.103066